|
시장보고서
상품코드
2075755
경추증 치료 시장 : 치료법별, 투여 경로별, 유통 채널별, 지역별Cervical Spondylosis Treatment Market, By Type of Treatment, By Route of Administration, By Distribution Channel, By Geography |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
경추증 치료 시장은 2026년에 63억 7,000만 달러 규모에 이를 것으로 추정되며, 2033년까지 94억 5,000만 달러에 이를 것으로 예상되고 있습니다. 2026-2033년 CAGR 5.8%로 성장할 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 : | 2025년 | 시장 규모(2026년) : | 63억 7,000만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간 CAGR(2026-2033년) : | 5.80% | 시장 규모 예측(2033년) : | 94억 5,000만 달러 |
경추증은 목에 영향을 미치는 퇴행성 질환의 일종입니다. 이는 경추(목)에서 노화에 따른 마모나 손상을 총칭하는 것으로, 목의 통증이나 뻣뻣함, 그 밖의 증상을 유발할 수 있습니다. 이러한 상태는 목 관절염이나 퇴행성 관절염이라고도 불립니다. 이는 목의 연골, 추간판, 인대, 뼈가 자연스럽게 마모되는 현상입니다. 매우 흔한 질환이며, 나이가 들면서 악화됩니다. 대부분의 경우, 특별한 치료는 필요하지 않습니다. 증상이 나타났을 때의 치료법으로는 약물 요법, 코르티코스테로이드 주사, 물리치료, 경우에 따라서는 수술 등이 있습니다.
시장 역학 :
경추증으로 인한 부담 증가, 목과 등 통증 유병률 상승, 고령 인구 증가, 그리고 전 세계적으로 안전하고 효과적인 경추증 치료에 대한 수요 증가가 세계 경추증 치료 시장의 성장을 견인할 것으로 예측됩니다.
예를 들어, 경추증은 고령자에서 척수증의 매우 흔한 원인입니다. 이는 노인에게서 가장 흔한 척추 기능 장애입니다. 매우 흔하며, 나이가 들면서 악화됩니다. 60세 이상 인구의 85% 이상이 경추증을 앓고 있습니다. 따라서 고령 인구 증가와 경추증으로 인한 부담의 확대에 따라, 안전하고 효과적인 경추증 치료에 대한 수요도 높아지고 있습니다. 세계보건기구(WHO)에 따르면, 2030년까지 전 세계 인구의 6명 중 1명이 60세 이상이 될 것이며, 2050년까지 전 세계 60세 이상 인구는 2배(21억 명)에 달할 것으로 예측됩니다.
본 조사의 주요 특징 :
- 본 조사에서는 다양한 부문의 잠재적 수익 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 본 조사에서는 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업들이 채택하는 경쟁 전략에 관한 중요한 인사이트도 제공합니다.
- 본 조사에서는 기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략 등의 지표를 바탕으로 세계 경추증 치료 시장의 주요 기업 프로파일을 소개했습니다.
- 본 보고서를 통해 얻은 인사이트를 바탕으로, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략에 대해 정보에 입각한 의사결정을 내릴 수 있게 됩니다.
- 이 책 '세계의 경추증 치료 시장' 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진출기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계의 경추증 치료 시장 분석에 활용되는 다양한 전략 매트릭스를 활용함으로써 의사결정을 원활하게 진행할 수 있을 것입니다.
목차
제1장 조사 목적 및 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 경추증 치료 시장 : 치료 방법별(2021-2033년)
제5장 경추증 치료 시장 : 투여 경로별(2021-2033년)
제6장 경추증 치료 시장 : 유통 채널별(2021-2033년)
제7장 경추증 치료 시장 : 지역별(2021-2033년)
제8장 경쟁 구도
제9장 섹션
AJY 26.07.09Cervical Spondylosis Treatment Market is estimated to be valued at USD 6.37 Bn in 2026 and is expected to reach USD 9.45 Bn by 2033, growing at a compound annual growth rate (CAGR) of 5.8% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 6.37 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 5.80% | 2033 Value Projection: | USD 9.45 Bn |
Cervical spondylosis is a type of degenerative disease that affects the neck. It is a general term for age-related wear and tear in the cervical spine (neck) that can lead to neck pain, neck stiffness, and other symptoms. Sometimes this condition is called arthritis or osteoarthritis of the neck. It is the natural wearing down of cartilage, disks, ligaments, and bones in the neck. It is very common and worsens with age. In many cases, no specific treatment is required. If symptoms occur, treatments include medication, corticosteroid injections, physiotherapy, and sometimes surgery.
Market Dynamics:
Rise in burden of cervical spondylosis, rising prevalence of neck and back pain, growing geriatric population, and increase in demand for safe & effective cervical spondylosis treatment around the globe is expected to propel the growth of the global cervical spondylosis treatment market.
For instance, cervical spondylosis is a very common cause of myelopathy in the elderly. It is the most common spine dysfunction in elderly people. It is very common and worsens with age. More than 85% of people older than age 60 are affected by cervical spondylosis. Thus, with the growing geriatric population and rise in burden of cervical spondylosis, the demand for safe and effective cervical spondylosis treatment is also increasing. As per the World Health Organization (WHO), by 2030, 1 in 6 people in the world will be aged 60 years or over, and the world's population of people aged 60 years and older will double (2.1 billion) by 2050.
Key features of the study:
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global cervical spondylosis treatment market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Medtronic plc, Zimmer Biomet Holdings, Inc., Stryker Corporation, Sanofi S.A., Johnson & Johnson Services, Inc., GlaxoSmithKline plc, Eli Lilly and Company, Amgen Inc., Merck & Co. Inc., Novartis AG, AstraZeneca Plc., Abbott Laboratories, Pfizer Inc., Bristol-Myers Squibb Company, and Teva Pharmaceutical Industries Ltd., among others.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global cervical spondylosis treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cervical spondylosis treatment market.
Detailed Segmentation:
- By Type of Treatment (Revenue, USD Bn, 2021 - 2033)
- Medication
- Physical Therapy
- Surgery
- By End-User (Revenue, USD Bn, 2021 - 2033)
- Hospitals
- Ambulatory Surgical Centers
- Homecare Settings
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Company Profiles:
- Medtronic plc
- Zimmer Biomet Holdings, Inc.
- Stryker Corporation
- Sanofi S.A.
- Johnson & Johnson Services, Inc.
- GlaxoSmithKline plc
- Eli Lilly and Company
- Amgen Inc.
- Merck & Co. Inc.
- Novartis AG
- AstraZeneca Plc.
- Abbott Laboratories
- Pfizer Inc.
- Bristol-Myers Squibb Company
- Teva Pharmaceutical Industries Ltd.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Cervical Spondylosis Treatment Market, By Type of Treatment
- Global Cervical Spondylosis Treatment Market, By Route of Administration
- Global Cervical Spondylosis Treatment Market, By Distribution Channel
- Global Cervical Spondylosis Treatment Market, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Cervical Spondylosis Treatment Market, By Type of Treatment, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Medication
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
- Corticosteroids
- Muscle relaxants
- Antidepressants
- Others
- Surgery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
5. Cervical Spondylosis Treatment Market, By Route of Administration, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Injection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
6. Cervical Spondylosis Treatment Market, By Distribution Channel, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
7. Cervical Spondylosis Treatment Market, By Region, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Treatment, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Treatment, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Treatment, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
- China
- Japan
- India
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Treatment, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Treatment, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Treatment, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (US$ Bn)
- North Africa
- Central Africa
- South Africa
8. Competitive Landscape
- Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Abbott Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- AstraZeneca Plc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Novartis AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merck & Co. Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Teva Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Amgen Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bristol-Myers Squibb Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Eli Lilly and Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- GlaxoSmithKline plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Johnson & Johnson Services, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sanofi S.A.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Stryker Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Zimmer Biomet Holdings, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Medtronic plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
9. Section
- Research Methodology
- About us
